BiVictriX Therapeutics makes "fundamental step forward"

Digital Asset Direct by BiVictriX Therapeutics PLC

London, UK | December 12, 2022 06:36 AM Eastern Standard Time

BiVictriX Therapeutics PLC (AIM:BVX, OTC:BVTXF) founder and CEO Tiffany Thorn speaks to Proactive about the "completely new approach" the company has been pioneering within the realm of oncology. She reveals more details about the "fundamental step" that BiVictrix has taken recently. Thorn also lays out her vision for the long-term future of the company.

Contact Details

Proactive

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Why News Direct

For Public Relations For Investor Relations Testimonials

About us Features News Hub

Resources

Press Blog

Why News Direct For Public Relations For Investor Relations Testimonials

What We Offer Collaborative Content Studio Advanced News Release Capability Standalone Multimedia Distribution Industry-Leading Security Unsurpassed Global Reach Actionable Analytics Synergistic PR Solutions

Pricing About us News Hub

Resources Blog Press